DE69535460D1 - Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie - Google Patents

Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie

Info

Publication number
DE69535460D1
DE69535460D1 DE69535460T DE69535460T DE69535460D1 DE 69535460 D1 DE69535460 D1 DE 69535460D1 DE 69535460 T DE69535460 T DE 69535460T DE 69535460 T DE69535460 T DE 69535460T DE 69535460 D1 DE69535460 D1 DE 69535460D1
Authority
DE
Germany
Prior art keywords
der
peptides
treatment
modified peptides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535460T
Other languages
English (en)
Other versions
DE69535460T2 (de
Inventor
Xian Chen
Sean Evans
Ze Ev Shaked
Henry M Franzen
Mei-Chang Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of DE69535460D1 publication Critical patent/DE69535460D1/de
Publication of DE69535460T2 publication Critical patent/DE69535460T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Navigation (AREA)
DE69535460T 1994-04-14 1995-04-12 Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie Expired - Lifetime DE69535460T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22777294A 1994-04-14 1994-04-14
US227772 1994-04-14
PCT/US1995/004481 WO1995028424A1 (en) 1994-04-14 1995-04-12 Pharmaceutical peptide formulations for treatment of dust mite allergy

Publications (2)

Publication Number Publication Date
DE69535460D1 true DE69535460D1 (de) 2007-05-24
DE69535460T2 DE69535460T2 (de) 2008-01-03

Family

ID=22854401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535460T Expired - Lifetime DE69535460T2 (de) 1994-04-14 1995-04-12 Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie

Country Status (12)

Country Link
EP (1) EP0755407B1 (de)
JP (1) JPH09512014A (de)
KR (1) KR100379161B1 (de)
AT (1) ATE359296T1 (de)
AU (1) AU717187B2 (de)
CA (1) CA2187329C (de)
DE (1) DE69535460T2 (de)
DK (1) DK0755407T3 (de)
ES (1) ES2285703T3 (de)
NZ (1) NZ284637A (de)
PT (1) PT755407E (de)
WO (1) WO1995028424A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888541B1 (de) 1996-03-21 2005-05-25 Circassia Limited Kryptische peptide und verfahren zu ihrer identifizierung
CA2263730A1 (en) * 1996-08-15 1998-02-19 Agrivax Incorporated Delivery of tolerogenic antigens via edible plants or plant-derived products
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
AT503530A1 (de) * 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CA2696563A1 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptides for vaccine
AU2013203568B2 (en) * 2007-08-15 2016-02-11 Circassia Limited Peptides for desensibilization against allergens
WO2010018384A1 (en) 2008-08-15 2010-02-18 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
MX2016008305A (es) 2013-12-23 2017-01-11 Alk-Abelló As Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU655599B2 (en) * 1990-09-11 1995-01-05 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
EP0623168B1 (de) * 1991-10-16 2009-09-30 Merck Patent GmbH T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Also Published As

Publication number Publication date
AU2286295A (en) 1995-11-10
KR100379161B1 (ko) 2003-06-11
KR970702295A (ko) 1997-05-13
EP0755407B1 (de) 2007-04-11
DK0755407T3 (da) 2007-08-06
ATE359296T1 (de) 2007-05-15
WO1995028424A1 (en) 1995-10-26
EP0755407A1 (de) 1997-01-29
NZ284637A (en) 1998-09-24
DE69535460T2 (de) 2008-01-03
ES2285703T3 (es) 2007-11-16
PT755407E (pt) 2007-07-20
CA2187329A1 (en) 1995-10-26
AU717187B2 (en) 2000-03-16
JPH09512014A (ja) 1997-12-02
CA2187329C (en) 2008-07-08

Similar Documents

Publication Publication Date Title
HUP0003280A1 (hu) Apolipoprotein A-1 agonista peptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
ATE169304T1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
FR2792202B1 (fr) Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
AU3368497A (en) Human dnase i hyperactive variants
DE69433666D1 (de) ENTZÜNDUNGSPROTEINE AUS MAKROPHAGEN MIP-3, MIP-4 UND MIP-1Gamma
DE50004018D1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
DE69535460D1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
TR199802537T2 (xx) Peptit t�revleri.
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DE69820053D1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
BR0312889A (pt) Polipeptìdeo t20 peguilado
DE69831257D1 (de) Histogranin peptide und deren analgetische verwendung
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
HUP0001458A2 (hu) Specifikus hasnyálmirigy lipáz inhibitor hatású peptidek, ezeket tartalmazó gyógyszerkészítmények és diagnosztikai reagensek, valamint ezek alkalmazása
WO2004050685A3 (en) Antifungal therapeutic agents
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
ATE384078T1 (de) Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
FI942938A (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
ATE230027T1 (de) Menschliche dnase i varianten
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition